Zhao Jingzhu, Chi Jiadong, Gao Ming, Zhi Jingtai, Li Yigong, Zheng Xiangqian
Resident, Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, and Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Resident, Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
J Oral Maxillofac Surg. 2017 Jul;75(7):1449.e1-1449.e8. doi: 10.1016/j.joms.2017.03.025. Epub 2017 Mar 23.
The aim of this study was to detect the relationship between phosphatase and tensin homolog deletion on chromosome 10 (PTEN) and microRNA 24 (miR-24) and correlate PTEN expression with important clinical parameters of patients with tongue squamous cell carcinoma (TSCC).
In this retrospective case series, all TSCC patients treated at Tianjin Medical University Cancer Institute and Hospital between March 2005 and October 2011 were retrospectively reviewed. Demographic information and clinical data (histologic type, clinical stage, tumor differentiation, and so on) were collected. The miR-24 level was detected by quantitative reverse transcription-polymerase chain reaction. The PTEN level was analyzed by immunohistochemistry and quantitative reverse transcription-polymerase chain reaction. Data analyses were performed by Spearman correlation analysis, Pearson χ test, and paired t test. Kaplan-Meier curves, log-rank analyses, and a Cox proportional hazards model were used to evaluate the prognostic value of PTEN.
A total of 90 patients (aged 59.4 ± 9.5 years, 53 men and 37 women) were identified. Loss of PTEN expression was detected in 27 of 90 tumors (30%)” in both occurrences [corrected]. The PTEN messenger RNA level was negatively correlated with the miR-24 level (r = -0.569, P < .01). PTEN expression also was negatively correlated with the miR-24 level (r = -0.621, P < .01). Furthermore, PTEN expression was significantly lower in cancer tissues than in adjacent normal tissues, and its expression was negatively correlated with clinical stage (P < .01) and positively correlated with differentiation (P < .05) in TSCC patients. In addition, the Kaplan-Meier curve indicated that loss of PTEN expression resulted in poor survival of TSCC patients (P < .01). Multivariate analysis indicated that PTEN expression level and clinical stage may be independent prognostic factors for TSCC patients.
This study suggested that PTEN expression was negatively correlated with the miR-24 level in TSCC. The loss of PTEN expression may serve as a predictor of unfavorable prognosis for TSCC patients.
本研究旨在检测10号染色体上的磷酸酶和张力蛋白同源物缺失(PTEN)与微小RNA 24(miR - 24)之间的关系,并将PTEN表达与舌鳞状细胞癌(TSCC)患者的重要临床参数相关联。
在这个回顾性病例系列中,对2005年3月至2011年10月期间在天津医科大学肿瘤研究所和医院接受治疗的所有TSCC患者进行了回顾性分析。收集了人口统计学信息和临床数据(组织学类型、临床分期、肿瘤分化等)。通过定量逆转录 - 聚合酶链反应检测miR - 24水平。通过免疫组织化学和定量逆转录 - 聚合酶链反应分析PTEN水平。数据分析采用Spearman相关性分析、Pearson χ检验和配对t检验。使用Kaplan - Meier曲线、对数秩分析和Cox比例风险模型评估PTEN的预后价值。
共纳入90例患者(年龄59.4 ± 9.5岁,男性53例,女性37例)。在90个肿瘤中的27个(30%)检测到PTEN表达缺失。PTEN信使核糖核酸水平与miR - 24水平呈负相关(r = -0.569,P <.01)。PTEN表达也与miR - 24水平呈负相关(r = -0.621,P <.01)。此外,在TSCC患者中,癌组织中PTEN表达明显低于相邻正常组织,其表达与临床分期呈负相关(P <.01),与分化呈正相关(P <.05)。此外,Kaplan - Meier曲线表明PTEN表达缺失导致TSCC患者生存率较低(P <.01)。多因素分析表明,PTEN表达水平和临床分期可能是TSCC患者的独立预后因素。
本研究表明,在TSCC中PTEN表达与miR - 24水平呈负相关。PTEN表达缺失可能是TSCC患者预后不良的一个预测指标。